Stem Cell Transplants Promising So Far in Type 1 Diabetes
NEW ORLEANS — Two patients with type 1 diabetes have now experienced improved blood glucose control with Vertex Pharmaceutical’s investigational allogeneic stem-cell derived islets (VX-880), with the first person now completely insulin-independent at 9 months post-transplant. Prior to the procedure, both patients had hypoglycemic unawareness and had experienced multiple episodes of severe hypoglycemia, conditions considered …
Stem Cell Transplants Promising So Far in Type 1 Diabetes Read More »









